Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.
about
Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resectionPatterns of colorectal cancer care in the United States and Canada: a systematic reviewSecular trends in mortality from common cancers in the United States by educational attainment, 1993-2001Efficacy, compliance and reasons for refusal of postoperative chemotherapy for elderly patients with colorectal cancer: a retrospective chart review and telephone patient questionnairePostoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicityPredictors of venous thromboembolism in patients with advanced common solid cancersComparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.Racial differences and disparities in cancer care and outcomes: where's the rub?Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgerySurvival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population.Differences among the elderly in the treatment costs of colorectal cancer: how important is race?Outcomes research: what is it and why does it matter?Sex differences in hospital readmission among colorectal cancer patients.The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patientsRace versus place of service in mortality among medicare beneficiaries with cancer.Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.Equity of access to elective surgery: reflections from NZ clinicians.In search of synergy: strategies for combining interventions at multiple levelsRacial disparities in cancer therapy: did the gap narrow between 1992 and 2002?Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer.Racial disparities in advanced-stage colorectal cancer survivalThe cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada.Inequity in colorectal cancer treatment and outcomes: a population-based study.External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews.Colorectal cancer treatment in older patients.Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service.The pathologist's role in rectal cancer patient assessments.Longitudinal patterns of chemotherapy use in metastatic colorectal cancer.Racial/Ethnic and Socioeconomic Differences in Colorectal and Breast Cancer Treatment Quality: The Role of Physician-level Variations in Care.Preoperative chemoradiotherapy for elderly patients with locally advanced rectal cancer-a real-world outcome study.Cancer in the elderly in the Czech Republic.Disparities in cancer care for older adults.Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.Management of locally advanced rectal cancer in the elderly: a critical review and algorithm.
P2860
Q24542266-15D55D33-9579-4D26-A930-31771F97C041Q26863029-D8ED8298-1DD5-43D2-B06A-57C77C467FF5Q28384895-258ED475-FFFF-4090-94C0-A9484628C9D1Q28486580-FB57A89A-FAA4-4D68-9811-49D2D16DC971Q30744596-95BE6751-3A52-46A9-A6FC-E7B20DB8B94AQ33367028-DA968F10-8130-4526-BE54-4BF7C5DBC4CAQ33810510-FEC414E1-9701-404E-841D-CF7C0B7D3C0CQ33989357-BBE2F1E7-C8D9-4ACC-8BB5-A164226056FCQ34269897-D1229C75-9E2B-4129-BEE1-723455C72C1EQ34336196-AC04C6B1-6E57-4E52-8667-7D3897F5442DQ35011194-2CBA7ED0-5E6D-419D-A4B4-76513880A2DAQ35071410-78C33E1E-0559-4446-80A4-B0DB5B2A24DAQ35072221-3CDB194F-B60D-4482-BE11-3B2A5A8D5B99Q35559361-E359BD03-D854-45C1-B708-C63647594977Q35683034-D644EBD7-E94B-43BC-B505-B945F732CC6AQ35751900-7A257E88-9482-4BC7-8572-490542440F81Q35866157-F26C2409-9DEF-4FDA-BD6B-78521BD7A432Q35931256-C83612C5-2681-43B7-B686-5074950DB212Q36352848-97184C15-A8A0-4B33-9E11-6517C645FC48Q36503071-4659F3A9-A56F-4CAA-A8D3-B2335ACE6DADQ36598736-AFFE3736-2506-4BCC-8B2D-096FBA7C45A3Q36614943-9E38B4C3-E248-4684-885C-19414141126AQ36742558-4A8E35D6-74B1-4F9A-95AF-709C751E6C37Q36785920-1F30DE15-DBCA-493E-9F9F-A8682F211283Q36936083-08A609A3-51E7-49A7-A094-9DD06DFB830BQ37073448-5FC37940-1B74-423C-B4DB-6E1FFB307542Q37094342-DD9F86ED-B0B6-4D19-B658-78D66B319826Q37462225-1010AAA2-E16A-41DC-9CB4-9FA116D77AACQ37466459-AFA3BB00-40A9-4A51-AF83-2F51654012A9Q39667442-A229CFDA-350E-4C4A-B995-C2419C4EC171Q40570629-6045DED6-F113-4B26-BF28-12D9FD0CD3EEQ41471262-40C9490B-FC05-459E-970E-52D037AA9E01Q42953304-A8D03B48-F0C8-42B7-8B6B-08A78B314A82Q45783553-222105AE-B31D-4214-ADF5-81C000EA1FF9Q54959817-F568ED23-66D0-4686-8213-84C3001EA669
P2860
Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Who gets adjuvant treatment fo ...... gy, and end results--Medicare.
@en
Who gets adjuvant treatment fo ...... gy, and end results--Medicare.
@nl
type
label
Who gets adjuvant treatment fo ...... gy, and end results--Medicare.
@en
Who gets adjuvant treatment fo ...... gy, and end results--Medicare.
@nl
prefLabel
Who gets adjuvant treatment fo ...... gy, and end results--Medicare.
@en
Who gets adjuvant treatment fo ...... gy, and end results--Medicare.
@nl
P2093
P1476
Who gets adjuvant treatment fo ...... gy, and end results--Medicare.
@en
P2093
P304
P356
10.1200/JCO.2001.19.17.3712
P407
P577
2001-09-01T00:00:00Z